US5320960A
(en)
*
|
1992-04-03 |
1994-06-14 |
Genencor International, Inc. |
Method of preparing solution enriched in xylanase using low molecular weight alcohol, organic salt and inorganic salt
|
US5780292A
(en)
*
|
1987-04-29 |
1998-07-14 |
Alko Group Ltd. |
Production of phytate degrading enzymes in trichoderma
|
US5298405A
(en)
*
|
1986-04-30 |
1994-03-29 |
Alko Limited |
Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production
|
US5610034A
(en)
*
|
1987-04-29 |
1997-03-11 |
Alko Group Ltd. |
Immunoglobulin production by trichoderma
|
US5258287A
(en)
*
|
1988-03-22 |
1993-11-02 |
Genentech, Inc. |
DNA encoding and methods of production of insulin-like growth factor binding protein BP53
|
EP0406314B1
(en)
*
|
1988-03-24 |
1993-12-01 |
Novo Nordisk A/S |
A cellulase preparation
|
CA1333777C
(en)
*
|
1988-07-01 |
1995-01-03 |
Randy M. Berka |
Aspartic proteinase deficient filamentous fungi
|
CA1341226C
(en)
*
|
1988-08-16 |
2001-05-01 |
Wim Van Hartingsveldt |
Gene replacement as a tool for the construction of aspergillus strains
|
FR2649120B1
(fr)
*
|
1989-06-30 |
1994-01-28 |
Cayla |
Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
|
US5120463A
(en)
*
|
1989-10-19 |
1992-06-09 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5688290A
(en)
*
|
1989-10-19 |
1997-11-18 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5837515A
(en)
*
|
1990-05-16 |
1998-11-17 |
Alko-Yhtiot Oy |
Enzyme preparations and methods for their production
|
FI903443A
(fi)
*
|
1990-07-06 |
1992-01-07 |
Valtion Teknillinen |
Framstaellning av lackas genom rekombinantorganismer.
|
AU657911B2
(en)
*
|
1990-07-16 |
1995-03-30 |
Roal Oy |
Immunoglobulin production by (Trichoderma)
|
US5246853A
(en)
*
|
1990-10-05 |
1993-09-21 |
Genencor International, Inc. |
Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
|
US5290474A
(en)
*
|
1990-10-05 |
1994-03-01 |
Genencor International, Inc. |
Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
|
US5650322A
(en)
*
|
1990-10-05 |
1997-07-22 |
Genencor International, Inc. |
Methods for stonewashing fabrics using endoglucanases
|
CA2093422C
(en)
*
|
1990-10-05 |
2001-04-03 |
|
DETERGENT COMPOSITIONS CONTAINING LOW CBH I CONTENT CELLULASE COMPOSITIONS
|
US5654193A
(en)
*
|
1990-10-05 |
1997-08-05 |
Genencor International, Inc. |
Methods for treating cotton containing fabrics with cellulase
|
US5328841A
(en)
*
|
1990-10-05 |
1994-07-12 |
Genencor International, Inc. |
Methods for isolating EG III cellulase component and EG III cellulase in polyethylene glycol using inorganic salt and polyethylene glycol
|
US5525507A
(en)
*
|
1990-10-05 |
1996-06-11 |
Genencor International, Inc. |
Methods for treating cotton-containing fabric with cellulase composition containing endoglucanase component and which is free of all CBH I component
|
WO1992010581A1
(en)
*
|
1990-12-10 |
1992-06-25 |
Genencor International, Inc. |
IMPROVED SACCHARIFICATION OF CELLULOSE BY CLONING AND AMPLIFICATION OF THE β-GLUCOSIDASE GENE OF TRICHODERMA REESEI
|
DE69202858T2
(de)
*
|
1991-03-22 |
1996-02-22 |
Novonordisk As |
Herstellungsverfahren für chymosin.
|
JPH07506404A
(ja)
*
|
1992-05-01 |
1995-07-13 |
ジェネンコア インターナショナル インコーポレーテッド |
綿含有織物をcbh iが多いセルラーゼで処理する方法
|
PT655890E
(pt)
*
|
1992-07-31 |
2005-05-31 |
Ab Enzymes Gmbh |
Celulas recombinantes, construcoes de adn, vectores e metodos para expressao de enzimas degradantes de fitato em proporcoes desejadas
|
US5665585A
(en)
*
|
1992-09-03 |
1997-09-09 |
Alko-Yhiot Oy |
Recombinant production of glucoamylase P in trichoderma
|
GB9400623D0
(en)
*
|
1994-01-14 |
1994-03-09 |
Univ Leeds |
Exploitation of the cellulase enzyme complex of neurospora
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US7816129B2
(en)
|
1994-07-29 |
2010-10-19 |
Ab Enzymes Gmbh |
Production and secretion of proteins of bacterial origin in filamentous fungi
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5700686A
(en)
*
|
1995-06-06 |
1997-12-23 |
Iogen Corporation |
Protease-treated and purified cellulase compositions and methods for reducing backstaining during enzymatic stonewashing
|
DE69628652T3
(de)
|
1995-09-08 |
2012-05-03 |
Genentech, Inc. |
Vegf-verwandtes protein
|
DE69734443T2
(de)
|
1996-01-08 |
2006-07-13 |
Genentech, Inc., South San Francisco |
Ob-rezeptor und liganden
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
DK0942992T3
(da)
|
1997-01-31 |
2007-07-02 |
Genentech Inc |
O-fucosyltransferase
|
US6100076A
(en)
|
1997-01-31 |
2000-08-08 |
Genentech, Inc. |
O-fucosyltransferase
|
PT1325932E
(pt)
|
1997-04-07 |
2005-06-30 |
Genentech Inc |
Anticorpos anti-vegf
|
WO1998045332A2
(en)
|
1997-04-07 |
1998-10-15 |
Genentech, Inc. |
Humanized antibodies and methods for forming humanized antibodies
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US6030619A
(en)
|
1997-08-27 |
2000-02-29 |
Chiron Corporation |
Molecular mimetics of meningococcal B epitopes
|
IL135607A0
(en)
|
1997-10-29 |
2001-05-20 |
Genentech Inc |
Wnt-1 inducible genes
|
CA2306183A1
(en)
|
1997-10-29 |
1999-05-06 |
Genentech, Inc. |
Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
PT1076703E
(pt)
|
1998-05-15 |
2007-10-10 |
Genentech Inc |
''utilizações terapêuticas de polipéptido homólogos de il-17''
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
EP1950300A3
(en)
|
1998-11-18 |
2011-03-23 |
Genentech, Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
PT1141331E
(pt)
|
1998-12-16 |
2008-12-22 |
Novartis Vaccines & Diagnostic |
Quinase dependente de ciclina humana (hpnqalre)
|
CA2450402A1
(en)
|
1998-12-22 |
2000-06-29 |
Genentech, Inc. |
Methods and compositions for inhibiting cancer cell growth comprising pro224
|
KR101077001B1
(ko)
|
1999-01-15 |
2011-10-26 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
EP1978029A3
(en)
|
1999-06-15 |
2008-10-15 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
ATE437655T1
(de)
|
1999-06-25 |
2009-08-15 |
Genentech Inc |
Humanisierte anti-erbb2 antikörper und behandlung mit anti-erbb2 antikörper
|
AU783767B2
(en)
|
1999-10-14 |
2005-12-01 |
Takara Bio Usa, Inc. |
Anthozoa derived chromophores/fluorophores and methods for using the same
|
AU2055401A
(en)
|
1999-12-01 |
2001-06-12 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1897947B1
(en)
|
1999-12-23 |
2012-01-18 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
ATE402258T1
(de)
|
2000-01-10 |
2008-08-15 |
Novartis Vaccines & Diagnostic |
Gene differentiell experimiert in brudtkrebs
|
WO2004043361A2
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP1272647B1
(en)
|
2000-04-11 |
2014-11-12 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
EP2792747A1
(en)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2168980A1
(en)
|
2000-06-23 |
2010-03-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
AU2001267333A1
(en)
|
2000-06-26 |
2002-01-08 |
Novozymes A/S |
Lipolytic enzyme
|
PT1303293E
(pt)
|
2000-07-27 |
2009-03-11 |
Genentech Inc |
Administração sequencial de cpt-11 e polipéptido apo-2l
|
DE60136281D1
(de)
|
2000-08-24 |
2008-12-04 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU8571901A
(en)
|
2000-09-05 |
2002-03-22 |
Novozymes As |
Lipoxygenase
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
FI120310B
(fi)
|
2001-02-13 |
2009-09-15 |
Valtion Teknillinen |
Parannettu menetelmä erittyvien proteiinien tuottamiseksi sienissä
|
CA2441580A1
(en)
|
2001-03-22 |
2002-10-03 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivatives
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
WO2002081642A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
EP1383874B1
(en)
|
2001-04-20 |
2009-12-23 |
Novozymes A/S |
Variants of lipoxygenase and their use
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
KR100607612B1
(ko)
|
2001-06-20 |
2006-08-02 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
PL368972A1
(en)
|
2001-08-29 |
2005-04-04 |
Genentech, Inc. |
Bv8 nucleic acids and polypeptides with mitogenic activity
|
EP2153843B1
(en)
|
2001-09-18 |
2012-08-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
AU2002333211B2
(en)
|
2001-09-27 |
2008-05-08 |
Novo Nordisk Health Care Ag |
Human coagulation factor VII polypeptides
|
SG159381A1
(en)
|
2001-10-10 |
2010-03-30 |
Novo Nordisk As |
Remodeling and glycoconjugation of peptides
|
EP2298354B1
(en)
|
2001-10-10 |
2014-03-19 |
ratiopharm GmbH |
Remodelling and glycoconjugation of interferon-beta
|
WO2003054158A2
(en)
|
2001-12-19 |
2003-07-03 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
US20030228305A1
(en)
|
2002-01-02 |
2003-12-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2388265A1
(en)
|
2002-02-22 |
2011-11-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
EP1571968A4
(en)
|
2002-04-16 |
2007-10-17 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TUMORS
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
JP2005528905A
(ja)
|
2002-06-07 |
2005-09-29 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
ES2376165T3
(es)
|
2002-07-15 |
2012-03-09 |
F. Hoffmann-La Roche Ag |
Tratamiento del c�?ncer con el anticuerpo dirigido contra erbb2 rhumab 2c4.
|
JP5401001B2
(ja)
|
2002-09-11 |
2014-01-29 |
ジェネンテック, インコーポレイテッド |
免疫関連疾患の治療のための新規組成物と方法
|
WO2004024072A2
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
DK2332996T3
(en)
|
2002-09-11 |
2014-12-15 |
Genentech Inc |
Purification of anti-Her2 antibodies
|
EP2444409A2
(en)
|
2002-09-16 |
2012-04-25 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20070042945A1
(en)
|
2002-09-25 |
2007-02-22 |
Genentech, Inc. |
Nouvelles compositions et methods de traitement du psoriasis
|
EP1576137A4
(en)
|
2002-10-29 |
2010-06-30 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM
|
US20070048301A1
(en)
|
2002-11-26 |
2007-03-01 |
Bodary-Winter Sarah C |
Compositions and methods for the treatment of immune related diseases
|
EP1572744B1
(en)
|
2002-12-16 |
2010-06-09 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
WO2004065417A2
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
JP4912144B2
(ja)
|
2003-03-12 |
2012-04-11 |
ジェネンテック, インコーポレイテッド |
造血促進のためのbv8及び/又はeg−vegfの使用
|
CN1798575A
(zh)
|
2003-04-04 |
2006-07-05 |
健泰科生物技术公司 |
高浓度抗体和蛋白制剂
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
RU2363731C2
(ru)
|
2003-04-28 |
2009-08-10 |
Новозимс А/С |
Полипептид с активностью фосфолипазы и его применение
|
KR20180014881A
(ko)
|
2003-05-30 |
2018-02-09 |
제넨테크, 인크. |
항-vegf 항체를 사용한 치료
|
CN1802386B
(zh)
|
2003-06-12 |
2010-12-15 |
伊莱利利公司 |
Glp-1类似物融合蛋白质
|
PL2784084T3
(pl)
|
2003-07-08 |
2020-03-31 |
Genentech, Inc. |
Przeciwciała antagonistyczne wobec heterologicznych polipeptydów IL-17A/F
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP4824559B2
(ja)
|
2003-09-09 |
2011-11-30 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
凝固因子viiポリペプチド
|
SI2161283T1
(sl)
|
2003-11-17 |
2014-10-30 |
Genentech, Inc. |
Sestavki, ki obsegajo protitelesa proti CD79b, konjugirana na sredstvo, ki inhibira rast, ali na citotoksično sredstvo, in postopki za zdravljenje tumorja hematopoetskega izvora
|
AU2004293789B2
(en)
|
2003-11-21 |
2009-07-23 |
Genencor International, Inc. |
Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
|
TR201815885T4
(tr)
|
2004-01-07 |
2018-11-21 |
Novartis Vaccines & Diagnostics Inc |
M-csf spesifik monoklonal antikorlar ve bunların kullanımı.
|
NZ548256A
(en)
|
2004-02-02 |
2010-02-26 |
Ambrx Inc |
Modified human four helical bundle polypeptides and their uses
|
US8097445B2
(en)
|
2004-03-25 |
2012-01-17 |
Danisco Us Inc. |
Exo-endo cellulase fusion protein
|
EP1735447A2
(en)
|
2004-03-25 |
2006-12-27 |
Genencor International, Inc. |
Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
|
US8268324B2
(en)
|
2004-03-29 |
2012-09-18 |
Galpharma Co., Ltd. |
Modified galectin 9 proteins and use thereof
|
SI1730191T1
(sl)
|
2004-03-30 |
2011-11-30 |
Glaxo Group Ltd |
Imunoglobulin-vezavni hOSM
|
WO2005100387A1
(en)
|
2004-04-07 |
2005-10-27 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
US20150017671A1
(en)
|
2004-04-16 |
2015-01-15 |
Yaping Shou |
Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
AU2004320371B2
(en)
|
2004-05-27 |
2011-09-22 |
Genencor International, Inc. |
Heterologous expression of an aspergillus kawachi acid-stable alpha amylase and applications in granular starch hydrolysis
|
US7332319B2
(en)
|
2004-05-27 |
2008-02-19 |
Genencor International, Inc. |
Heterologous alpha amylase expression in Aspergillus
|
US7413887B2
(en)
|
2004-05-27 |
2008-08-19 |
Genecor International, Inc. |
Trichoderma reesei glucoamylase and homologs thereof
|
CN1997735B
(zh)
|
2004-05-27 |
2012-02-22 |
金克克国际有限公司 |
白曲霉酸稳定性α淀粉酶和在颗粒淀粉水解中的应用
|
KR20070034512A
(ko)
|
2004-06-18 |
2007-03-28 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
EP2361931B1
(en)
|
2004-07-20 |
2017-12-06 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
FI118339B
(fi)
|
2004-09-21 |
2007-10-15 |
Ab Enzymes Oy |
Uusi lakkaasientsyymi ja sen käyttö
|
CA2586313C
(en)
|
2004-11-10 |
2016-03-08 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
CN103690936A
(zh)
|
2004-12-22 |
2014-04-02 |
Ambrx公司 |
经修饰的人类生长激素
|
CA2927595C
(en)
|
2004-12-22 |
2023-01-31 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
EP2230517A1
(en)
|
2005-01-07 |
2010-09-22 |
Diadexus, Inc. |
OVR110 antibody compositions and methods of use
|
US8034600B2
(en)
|
2005-02-18 |
2011-10-11 |
Danisco Us Inc. |
Polypeptides having alpha-amylase and granular starch hydrolyzing activity
|
NZ561681A
(en)
|
2005-03-21 |
2011-01-28 |
Virobay Inc |
Alpha ketoamide compounds as cysteine protease inhibitors
|
EP2123746B1
(en)
|
2005-04-12 |
2016-11-16 |
Danisco US Inc. |
Gene inactivated mutants with altered protein production
|
US7741093B2
(en)
|
2005-04-29 |
2010-06-22 |
Ab Enzymes Oy |
Cellulases and their uses
|
ATE515512T1
(de)
|
2005-05-12 |
2011-07-15 |
Zymogenetics Inc |
Zusammensetzungen und verfahren zur modulierung von immunreaktionen
|
AU2006255686A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
CA2619577A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
WO2007031559A2
(en)
|
2005-09-14 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7749704B2
(en)
|
2005-11-01 |
2010-07-06 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the BLyS gene and use in diagnostic methods
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
AU2006315347A1
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
SI1948798T1
(sl)
|
2005-11-18 |
2015-09-30 |
Glenmark Pharmaceuticals S.A. |
Anti-alfa 2 integrin protitelesa in njihova uporaba
|
US20090293137A1
(en)
|
2005-11-21 |
2009-11-26 |
Genentech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
US7256032B2
(en)
|
2005-12-22 |
2007-08-14 |
Ab Enzymes Oy |
Enzymes
|
MX2008008225A
(es)
|
2005-12-22 |
2008-10-01 |
Ab Enzymes Oy |
Nuevas enzimas.
|
US20080311107A1
(en)
|
2006-02-17 |
2008-12-18 |
Genetech, Inc. |
Novel Gene Disruptions, Compositions and Methods Relating Thereto
|
WO2007109376A2
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
EP2614839A3
(en)
|
2006-04-05 |
2015-01-28 |
Genentech, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
KR20140071452A
(ko)
|
2006-04-05 |
2014-06-11 |
애브비 바이오테크놀로지 리미티드 |
항체 정제
|
US7361487B2
(en)
|
2006-04-13 |
2008-04-22 |
Ab Enzymes Oy |
Enzyme fusion proteins and their use
|
EP2082645A1
(en)
|
2006-04-19 |
2009-07-29 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
WO2007127936A2
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
CA2652452C
(en)
|
2006-05-15 |
2018-07-31 |
Sea Lane Biotechnologies, Llc |
Neutralizing antibodies to influenza viruses
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
CN101563363B
(zh)
|
2006-06-21 |
2013-01-02 |
南卡罗来纳医疗大学研究发展基金会 |
用于治疗疾病的靶向补体因子h
|
ES2531933T3
(es)
|
2006-06-30 |
2015-03-20 |
Novo Nordisk A/S |
Anticuerpos anti-NKG2A y usos de los mismos
|
US20080026376A1
(en)
|
2006-07-11 |
2008-01-31 |
Huaming Wang |
KEX2 cleavage regions of recombinant fusion proteins
|
CA2661023C
(en)
|
2006-08-18 |
2017-08-15 |
Novartis Ag |
Prlr-specific antibody and uses thereof
|
CA2663083A1
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
WO2008045489A2
(en)
|
2006-10-10 |
2008-04-17 |
Danisco Us, Inc. Genencor Division |
Glucoamylase variants with altered properties
|
CA2667706A1
(en)
|
2006-10-27 |
2008-05-08 |
Lpath, Inc. |
Compositions and methods for treating ocular diseases and conditions
|
RU2460541C2
(ru)
|
2006-10-27 |
2012-09-10 |
Лпат, Инк. |
Композиции и способы связывания сфингозин-1-фосфата
|
US20080254512A1
(en)
|
2006-11-02 |
2008-10-16 |
Capon Daniel J |
Hybrid immunoglobulins with moving parts
|
MX2009004757A
(es)
|
2006-11-14 |
2009-05-21 |
Genentech Inc |
Moduladores de regeneracion neuronal.
|
US8470332B2
(en)
|
2006-11-22 |
2013-06-25 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
WO2008067283A2
(en)
|
2006-11-27 |
2008-06-05 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
EA200900767A1
(ru)
|
2006-12-07 |
2009-12-30 |
Новартис Аг |
Антагонистические антитела против ephb3
|
ATE526017T1
(de)
|
2007-01-22 |
2011-10-15 |
Genentech Inc |
Abscheidung von polyelektrolyten und reinigung von antikörpern
|
US20100144599A1
(en)
|
2007-02-02 |
2010-06-10 |
Bristol-Myers Squibb Company |
Vegf pathway blockade
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
US20080220498A1
(en)
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
WO2008103962A2
(en)
|
2007-02-22 |
2008-08-28 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
US8916369B2
(en)
|
2007-03-14 |
2014-12-23 |
Danisco Us Inc. |
Trichoderma reesei α-amylase is a maltogenic enzyme
|
WO2008121563A2
(en)
|
2007-03-30 |
2008-10-09 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
DK2147104T3
(en)
|
2007-05-21 |
2015-12-14 |
Danisco Us Inc |
USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION
|
US9163091B2
(en)
|
2007-05-30 |
2015-10-20 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
EP2164992B1
(en)
|
2007-05-30 |
2016-05-04 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
CA2690124A1
(en)
|
2007-06-07 |
2008-12-18 |
Genentech, Inc. |
C3b antibodies and methods for the prevention and treatment of complement-associated disorders
|
LT3597659T
(lt)
|
2007-07-09 |
2023-05-10 |
Genentech, Inc. |
Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu
|
CN111499748A
(zh)
|
2007-07-16 |
2020-08-07 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
PE20090481A1
(es)
|
2007-07-16 |
2009-05-18 |
Genentech Inc |
Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
WO2009031992A1
(en)
*
|
2007-09-04 |
2009-03-12 |
Elizabeth Varriano-Marston |
Method for controlling banana quality by packaging
|
WO2009035500A1
(en)
|
2007-09-12 |
2009-03-19 |
Danisco Us Inc., Genencor Division |
Trichoderma promoter
|
AU2008308509B2
(en)
|
2007-10-04 |
2014-10-23 |
Zymogenetics, Inc. |
B7 family member zB7H6 and related compositions and methods
|
ES2516265T3
(es)
|
2007-10-09 |
2014-10-30 |
Danisco Us Inc. |
Variantes de glucoamilasa con propiedades modificadas
|
US8592194B2
(en)
|
2007-10-09 |
2013-11-26 |
Danisco Us Inc. |
Glucoamylase variants with altered properties
|
US8361465B2
(en)
|
2007-10-26 |
2013-01-29 |
Lpath, Inc. |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
|
SI2215117T2
(en)
|
2007-10-30 |
2018-04-30 |
Genentech, Inc. |
Purification of the antibody by cation exchange chromatography
|
US8679749B2
(en)
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
JP2011503094A
(ja)
|
2007-11-08 |
2011-01-27 |
ジェネンテック, インコーポレイテッド |
抗b因子抗体およびそれらの使用
|
AU2008321016B2
(en)
|
2007-11-12 |
2013-03-28 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
DK2222842T3
(en)
|
2007-11-20 |
2015-01-19 |
Danisco Us Inc |
Glucoamylasevarianter with changed properties
|
NZ603812A
(en)
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
US8003325B2
(en)
|
2007-11-30 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the BLyS gene and use in diagnostic methods
|
TWI580694B
(zh)
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
抗-vegf抗體
|
KR20100118973A
(ko)
|
2007-12-13 |
2010-11-08 |
다니스코 유에스 인크. |
이소프렌을 생성하기 위한 조성물 및 방법
|
CN101918545A
(zh)
|
2008-01-02 |
2010-12-15 |
丹尼斯科美国公司 |
应用嗜糖假单胞菌g4-淀粉酶和其变体获得乙醇的无葡糖淀粉酶的方法
|
AR070141A1
(es)
|
2008-01-23 |
2010-03-17 |
Glenmark Pharmaceuticals Sa |
Anticuerpos humanizados especificos para el factor von willebrand
|
WO2009092805A1
(en)
|
2008-01-24 |
2009-07-30 |
Novo Nordisk A/S |
Humanized anti-human nkg2a monoclonal antibody
|
EP3269737B1
(en)
|
2008-01-31 |
2024-06-19 |
Genentech, Inc. |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
WO2009102755A1
(en)
|
2008-02-11 |
2009-08-20 |
Danisco Us Inc., Genencor Division |
Enzyme with microbial lysis activity from trichoderma reesei
|
CA2718878A1
(en)
|
2008-03-10 |
2009-09-17 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of cytomegalovirus
|
AU2009228058A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
KR101855381B1
(ko)
|
2008-04-09 |
2018-05-09 |
제넨테크, 인크. |
면역 관련 질병의 치료를 위한 신규한 조성물 및 방법
|
PL3118309T3
(pl)
|
2008-04-18 |
2021-05-31 |
Danisco Us Inc. |
Warianty fitazy buttiauxella sp.
|
JP2011518564A
(ja)
|
2008-04-23 |
2011-06-30 |
ダニスコ・ユーエス・インク |
改良された微生物によるイソプレン産出用のイソプレンシンターゼ変異体
|
AU2009244300B2
(en)
|
2008-05-06 |
2014-04-17 |
Genentech, Inc. |
Affinity matured CRIg variants
|
MY156256A
(en)
|
2008-07-02 |
2016-01-29 |
Danisco Us Inc |
Compositions and methods for producing isoprene free of c5 hydrocarbons under decoupling conditions and/or safe operating ranges
|
EP3225248B1
(en)
|
2008-07-23 |
2023-06-07 |
Ambrx, Inc. |
Modified bovine g-csf polypeptides and their uses
|
LT2848625T
(lt)
|
2008-08-14 |
2019-10-10 |
Genentech, Inc. |
Priemaišų pašalinimo būdai, panaudojant reziduojančio baltymo pakeitimą jonų mainų membraninės chromatografijos pagalba
|
PE20100269A1
(es)
|
2008-09-05 |
2010-04-30 |
TransAlgae Ltd |
Resistencia a herbicida para mantener cultivos axenicos por manipulacion genetica
|
EP2344629B1
(en)
|
2008-09-15 |
2018-01-24 |
Danisco US Inc. |
Systems using cell culture for production of isoprene
|
MY169163A
(en)
|
2008-09-15 |
2019-02-19 |
Danisco Us Inc |
Increased isoprene production using the archaeal lower mevalonate pathway
|
EP2337844A1
(en)
|
2008-09-15 |
2011-06-29 |
Danisco US Inc. |
Reduction of carbon dioxide emission during isoprene production by fermentation
|
CA2737195A1
(en)
|
2008-09-15 |
2010-03-18 |
The Goodyear Tire & Rubber Company |
Conversion of prenyl derivatives to isoprene
|
WO2010034015A2
(en)
|
2008-09-22 |
2010-03-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
CA2737026C
(en)
|
2008-09-26 |
2019-12-24 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
CA2738033C
(en)
|
2008-09-26 |
2019-11-26 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
EP2921501A1
(en)
|
2008-10-20 |
2015-09-23 |
Abbvie Inc. |
Isolation and purification of antibodies using Protein A affinity chromatography
|
JP5851838B2
(ja)
|
2008-10-22 |
2016-02-03 |
ジェネンテック, インコーポレイテッド |
軸索変性の調節
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
AU2009312532B2
(en)
|
2008-11-06 |
2013-05-16 |
Ichnos Sciences SA |
Treatment with anti-alpha2 integrin antibodies
|
DK2358873T4
(en)
|
2008-12-15 |
2018-05-28 |
Danisco Us Inc |
HYBRID ALPHA AMYLASER
|
UY32341A
(es)
|
2008-12-19 |
2010-07-30 |
Glaxo Group Ltd |
Proteínas de unión antígeno novedosas
|
FI20086236A0
(fi)
|
2008-12-23 |
2008-12-23 |
Valtion Teknillinen |
Heksuronihapon konversio heksarihapoksi
|
WO2010078376A2
(en)
|
2008-12-30 |
2010-07-08 |
Ventana Medical Systems, Inc. |
Fc-specific polymer-conjugated antibodies and their diagnostic use
|
FI122029B
(fi)
|
2008-12-30 |
2011-07-29 |
Ab Enzymes Oy |
Sieniperäiset endoglukanaasit, niiden tuotto ja käyttö
|
SG172806A1
(en)
|
2008-12-30 |
2011-08-29 |
Danisco Us Inc |
Methods of producing isoprene and a co-product
|
WO2010091122A1
(en)
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
JP6132548B2
(ja)
|
2009-04-01 |
2017-05-24 |
ジェネンテック, インコーポレイテッド |
抗FcRH5抗体および免疫接合体および使用方法
|
US20100297127A1
(en)
|
2009-04-08 |
2010-11-25 |
Ghilardi Nico P |
Use of il-27 antagonists to treat lupus
|
WO2010124146A2
(en)
|
2009-04-23 |
2010-10-28 |
Danisco Us Inc. |
Three-dimensional structure of isoprene synthase and its use thereof for generating variants
|
WO2010124163A2
(en)
|
2009-04-23 |
2010-10-28 |
Theraclone Sciences, Inc. |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
FI121712B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Uusi sieniperäinen proteaasi ja sen käyttö
|
FI121711B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Sieniperäinen seriiniproteaasi ja sen käyttö
|
DK3473711T3
(da)
|
2009-05-19 |
2021-01-04 |
Dupont Nutrition Biosci Aps |
Amylasepolypeptider
|
CA2762302A1
(en)
|
2009-05-20 |
2010-11-25 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
AU2010258898B8
(en)
|
2009-06-08 |
2015-02-05 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
EA030619B1
(ru)
|
2009-06-08 |
2018-09-28 |
Амуникс Оперейтинг Инк. |
Гибридный белок, включающий последовательности гормона роста и xten, способ его получения и применения
|
TW201412988A
(zh)
|
2009-06-17 |
2014-04-01 |
Danisco Us Inc |
使用dxp及mva途徑之改良之異戊二烯製造
|
TWI434921B
(zh)
|
2009-06-17 |
2014-04-21 |
Danisco Us Inc |
從生物異戊二烯組合物製造燃料成分之方法及系統
|
FI121851B
(fi)
|
2009-07-08 |
2011-05-13 |
Ab Enzymes Oy |
Sieniperäinen proteaasi ja sen käyttö
|
JP2012533306A
(ja)
|
2009-07-15 |
2012-12-27 |
アボット・ラボラトリーズ |
機械的伝達による細胞産生の強化
|
WO2011006982A2
(en)
|
2009-07-17 |
2011-01-20 |
Rigshospitalet |
Inhibitors of complement activation
|
US8765431B2
(en)
|
2009-07-23 |
2014-07-01 |
The Regents Of The University Of Michigan |
Method for enzymatic production of decarboxylated polyketides and fatty acids
|
MX2012001306A
(es)
|
2009-07-31 |
2012-02-28 |
Genentech Inc |
Inhibicion de matastasis de tumor.
|
EP2467475A1
(en)
|
2009-08-19 |
2012-06-27 |
Danisco US Inc. |
Combinatorial variants of glucoamylase with improved specific activity and/or thermostability
|
AR077942A1
(es)
|
2009-08-19 |
2011-10-05 |
Danisco |
Variantes de glucoamilasa
|
US20120263701A1
(en)
|
2009-08-24 |
2012-10-18 |
Volker Schellenberger |
Coagulation factor vii compositions and methods of making and using same
|
CN108409829A
(zh)
|
2009-09-01 |
2018-08-17 |
弗·哈夫曼-拉罗切有限公司 |
通过改进的a蛋白洗脱增强的蛋白质纯化
|
WO2011028950A1
(en)
|
2009-09-02 |
2011-03-10 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US9885711B2
(en)
|
2009-09-25 |
2018-02-06 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
EP2488643A4
(en)
|
2009-10-15 |
2013-07-03 |
Hoffmann La Roche |
CHIMERIC FIBROBLAST GROWTH FACTORS WITH CHANGED RECEPTOR SPECIFICITY
|
MX2012004711A
(es)
|
2009-10-20 |
2012-05-23 |
Abbott Lab |
Aislamiento y purificacion de los anticuerpos anti-il-13 al usar cromatografia de afinidad con proteina a.
|
CN102711826B
(zh)
|
2009-10-22 |
2017-03-29 |
霍夫曼-拉罗奇有限公司 |
用于调控巨噬细胞刺激性蛋白的hepsin活化的方法和组合物
|
AU2010310589A1
(en)
|
2009-10-22 |
2012-05-10 |
Genentech, Inc. |
Modulation of axon degeneration
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
US20110098862A1
(en)
|
2009-10-27 |
2011-04-28 |
ExxonMobil Research Engineering Company Law Department |
Multi-stage processes and control thereof
|
WO2011060246A2
(en)
|
2009-11-12 |
2011-05-19 |
Genentech, Inc. |
A method of promoting dendritic spine density
|
PE20121584A1
(es)
|
2009-11-30 |
2012-11-29 |
Genentech Inc |
Composiciones y metodos para el diagnostico y el tratamiento de tumores
|
JP5931738B2
(ja)
|
2009-12-01 |
2016-06-08 |
ノヴォ ノルディスク アー/エス |
新規のペプチジルアルファ−ヒドロキシグリシンアルファ−アミド化リアーゼ
|
US8486397B2
(en)
|
2009-12-11 |
2013-07-16 |
Genentech, Inc. |
Anti-VEGF-C antibodies and methods using same
|
WO2011080050A2
(en)
|
2009-12-11 |
2011-07-07 |
Novartis Ag |
Binding molecules
|
JP5984676B2
(ja)
|
2009-12-18 |
2016-09-06 |
シーエスエル、リミテッド |
ポリペプチドを精製する方法
|
CN102770158B
(zh)
|
2009-12-21 |
2016-10-19 |
霍夫曼-拉罗奇有限公司 |
抗体配制剂
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
FI122937B
(fi)
|
2009-12-30 |
2012-09-14 |
Roal Oy |
Menetelmä selluloosamateriaalin käsittelemiseksi sekä tässä käyttökelpoiset CBH II/Cel6A entsyymit
|
SG182590A1
(en)
|
2010-01-28 |
2012-08-30 |
Glaxo Group Ltd |
Cd127 binding proteins
|
JP5972176B2
(ja)
|
2010-02-23 |
2016-08-17 |
サノフイ |
抗アルファ2インテグリン抗体及びそれらの使用
|
AR080243A1
(es)
|
2010-02-23 |
2012-03-21 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
EP2542569B1
(en)
|
2010-03-05 |
2020-09-16 |
Omeros Corporation |
Chimeric inhibitor molecules of complement activation
|
DK2552945T3
(en)
|
2010-03-29 |
2018-07-16 |
Dupont Nutrition Biosci Aps |
POLYPEPTIDES WITH TRANSGALACTOSYLATION ACTIVITY
|
BR112012024713B1
(pt)
|
2010-03-31 |
2021-02-17 |
Boehringer Ingelheim International Gmbh |
anticorpo humanizado, seus usos e composição farmacêutica que o compreende
|
EP2552967A4
(en)
|
2010-04-02 |
2014-10-08 |
Amunix Operating Inc |
BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
MA34291B1
(fr)
|
2010-05-03 |
2013-06-01 |
Genentech Inc |
Compositions et méthodes de diagnostic et de traitement d'une tumeur
|
MX343604B
(es)
|
2010-05-28 |
2016-11-11 |
Genentech Inc |
Disminuir nivel de lactato e incrementar producción de polipéptidos por regulación a la baja de la expresión de lactato dehidrogenasa y piruvato dehidrogenasa quinasa.
|
US9169329B2
(en)
|
2010-06-01 |
2015-10-27 |
Ludwig Institute For Cancer Research |
Antibodies directed to the receptor tyrosine kinase c-Met
|
AR081556A1
(es)
|
2010-06-03 |
2012-10-03 |
Glaxo Group Ltd |
Proteinas de union al antigeno humanizadas
|
US8933282B2
(en)
|
2010-06-17 |
2015-01-13 |
Danisco Us Inc. |
Fuel compositions comprising isoprene derivatives
|
KR101768118B1
(ko)
|
2010-06-25 |
2017-08-14 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
기도 감염의 치료를 위한 방법 및 약학 조성물
|
WO2012010635A1
(en)
|
2010-07-22 |
2012-01-26 |
Glaxosmithkline Biologicals S.A. |
Novel antigen binding proteins
|
BR112013001179A2
(pt)
|
2010-08-06 |
2016-05-31 |
Danisco Us Inc |
sacrificação e fermentação em ph neutro.
|
EP2601300A1
(en)
|
2010-08-06 |
2013-06-12 |
Danisco US Inc. |
Production of isoprene under neutral ph conditions
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
WO2012021786A2
(en)
|
2010-08-12 |
2012-02-16 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
EP2603525A1
(en)
|
2010-08-13 |
2013-06-19 |
F.Hoffmann-La Roche Ag |
Antibodies to il-1beta and il-18, for treatment of disease
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
DK2605789T3
(da)
|
2010-08-17 |
2019-09-16 |
Ambrx Inc |
Modificerede relaxinpolypeptider og anvendelser deraf
|
CN103068264A
(zh)
|
2010-08-24 |
2013-04-24 |
丹尼斯科美国公司 |
包含低温大米蛋白浓缩物的食品产品
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
EP2611465A4
(en)
|
2010-08-31 |
2014-06-04 |
Theraclone Sciences Inc |
NEUTRALIZING ANTI-VIRUS ANTIBODIES FOR HUMAN IMMUNODEFICIENCY (HIV)
|
CA2811403A1
(en)
|
2010-09-15 |
2012-03-22 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
RU2608499C2
(ru)
|
2010-09-20 |
2017-01-18 |
Эббви Инк. |
Очистка антител с помощью хроматографии с псевдодвижущимся слоем
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
AU2011312205B2
(en)
|
2010-10-05 |
2015-08-13 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
EP2624856B1
(en)
|
2010-10-08 |
2016-12-14 |
Shanghai Kexin Biotech Co., Ltd |
Moesin fragments for use in the diagnosis of immune thrombocytopenia
|
CA2814023C
(en)
|
2010-10-08 |
2018-01-16 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments and uses thereof
|
JP5868410B2
(ja)
|
2010-10-08 |
2016-02-24 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
再生不良性貧血と関連しているモエシン断片
|
KR101687060B1
(ko)
|
2010-10-08 |
2016-12-15 |
상하이 켁신 바이오테크 씨오., 엘티디. |
모에신 조절제 및 그의 용도
|
KR101631740B1
(ko)
|
2010-10-08 |
2016-06-17 |
상하이 켁신 바이오테크 씨오., 엘티디. |
모에신 단편의 진단학적 및 치료학적 용도
|
US9273298B2
(en)
|
2010-10-27 |
2016-03-01 |
Danisco Us Inc. |
Isoprene synthase variants for improved production of isoprene
|
FI123942B
(fi)
|
2010-10-29 |
2013-12-31 |
Ab Enzymes Oy |
Sieniperäisen seriiniproteaasin variantteja
|
RS55161B1
(sr)
|
2010-11-04 |
2017-01-31 |
Boehringer Ingelheim Int |
Anti-il-23 antitela
|
US9068970B2
(en)
|
2010-11-05 |
2015-06-30 |
Abbvie Inc. |
Efficient and effective supplement screening for the development of chemically defined media in cell culture
|
US20140199682A1
(en)
|
2010-11-17 |
2014-07-17 |
Sea Lane Biotechnologies, Llc |
Influenza neutralizing agents
|
BR112013016264A2
(pt)
|
2010-12-22 |
2018-06-19 |
Danisco Us Inc |
produção biológica de açúcares de pentose com o uso de células recombinantes
|
US8685702B2
(en)
|
2010-12-22 |
2014-04-01 |
Danisco Us Inc. |
Compositions and methods for improved isoprene production using two types of ISPG enzymes
|
WO2012083370A1
(en)
|
2010-12-22 |
2012-06-28 |
Cephalon Australia Pty Ltd |
Modified antibody with improved half-life
|
WO2012112489A2
(en)
|
2011-02-14 |
2012-08-23 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
WO2012122528A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Bispecific three-chain antibody-like molecules
|
WO2012125735A1
(en)
|
2011-03-15 |
2012-09-20 |
Abott Laboratories |
An integrated approach to the isolation and purification of antibodies
|
CN103533929A
(zh)
|
2011-03-15 |
2014-01-22 |
特罗科隆科学有限公司 |
用于流行性感冒的治疗和诊断的组合物和方法
|
EP2689250A1
(en)
|
2011-03-23 |
2014-01-29 |
AbbVie Inc. |
Methods and systems for the analysis of protein samples
|
WO2012135589A1
(en)
|
2011-03-31 |
2012-10-04 |
Genentech, Inc. |
Methods of administering beta7 integrin antagonists
|
FI123425B
(fi)
|
2011-03-31 |
2013-04-30 |
Ab Enzymes Oy |
Proteaasientsyymi ja sen käytöt
|
WO2012149197A2
(en)
|
2011-04-27 |
2012-11-01 |
Abbott Laboratories |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
BR112013027170A2
(pt)
|
2011-04-29 |
2017-06-20 |
Danisco Us Inc |
processo em ph único para liquefação e sacarificação de amido para xaropes de glicose de densidade alta
|
EP2710042A2
(en)
|
2011-05-16 |
2014-03-26 |
Fabion Pharmaceuticals, Inc. |
Multi-specific fab fusion proteins and methods of use
|
EP2714735B1
(en)
|
2011-06-03 |
2021-07-21 |
XOMA Technology Ltd. |
Antibodies specific for tgf-beta
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
EP2731677B1
(en)
|
2011-07-11 |
2018-04-18 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to ox40 and their uses
|
US8951764B2
(en)
|
2011-08-05 |
2015-02-10 |
Danisco Us Inc. |
Production of isoprenoids under neutral pH conditions
|
WO2013025944A1
(en)
|
2011-08-17 |
2013-02-21 |
Genentech, Inc. |
Inhibition of angiogenesis in refractory tumors
|
US8822651B2
(en)
|
2011-08-30 |
2014-09-02 |
Theraclone Sciences, Inc. |
Human rhinovirus (HRV) antibodies
|
US20160137711A1
(en)
|
2011-09-12 |
2016-05-19 |
Amunix Operating Inc. |
Glucagon-like peptide-2 compositions and methods of making and using same
|
AU2012311492A1
(en)
|
2011-09-23 |
2014-03-06 |
Amgen Research (Munich) Gmbh |
Bispecific binding molecules for 5T4 and CD3
|
WO2013067026A1
(en)
|
2011-10-31 |
2013-05-10 |
Bp Corporation North America Inc. |
Use of plant promoters in filamentous fungi
|
CA2851308A1
(en)
|
2011-10-31 |
2013-05-10 |
Bp Corporation North America Inc. |
Use of mammalian promoters in filamentous fungi
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
KR20200110476A
(ko)
|
2011-11-16 |
2020-09-23 |
베링거 인겔하임 인터내셔날 게엠베하 |
항 il-36r 항체
|
CA2857168C
(en)
|
2011-12-01 |
2020-10-27 |
Protevobio, Inc. |
Protein inhibitors to complement and vegf pathways and methods of use thereof
|
JP6415326B2
(ja)
|
2011-12-16 |
2018-10-31 |
ブラスケム エス.エー. |
改変された微生物およびそれを用いてブタジエンを作製する方法
|
WO2013091903A1
(en)
|
2011-12-22 |
2013-06-27 |
Novo Nordisk A/S |
Anti-crac channel antibodies
|
SG11201403437TA
(en)
|
2011-12-22 |
2014-07-30 |
Genentech Inc |
Ion exchange membrane chromatography
|
JP6310398B2
(ja)
|
2012-01-19 |
2018-04-11 |
ユニバーシティ・オブ・シンシナティ |
非グリコシル化アポリポタンパク質a−ivを用いて糖尿病を処置する方法
|
WO2013116287A1
(en)
|
2012-01-31 |
2013-08-08 |
Genentech, Inc. |
Anti-ig-e m1' antibodies and methods using same
|
CA2861051C
(en)
|
2012-02-09 |
2021-06-22 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
LT2814840T
(lt)
|
2012-02-15 |
2020-02-25 |
Bioverativ Therapeutics Inc. |
Faktoriaus viii kompozicijos ir jų gavimo ir naudojimo būdai
|
EP2822577B1
(en)
|
2012-02-15 |
2019-02-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor viii proteins
|
EP2820047B1
(en)
|
2012-03-01 |
2018-04-25 |
Amgen Research (Munich) GmbH |
Long life polypeptide binding molecules
|
WO2013158275A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Cell culture methods to reduce acidic species
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
DK2841087T3
(da)
|
2012-04-27 |
2017-11-20 |
Us Health |
Vaskulær endothel-vækstfaktor-antagonister og fremgangsmåder til anvendelse deraf
|
US9163263B2
(en)
|
2012-05-02 |
2015-10-20 |
The Goodyear Tire & Rubber Company |
Identification of isoprene synthase variants with improved properties for the production of isoprene
|
EP2844284A1
(en)
|
2012-05-03 |
2015-03-11 |
Boehringer Ingelheim International GmbH |
Anti-il-23p19 antibodies
|
US20140010820A1
(en)
|
2012-05-21 |
2014-01-09 |
Abbvie, Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
LT3473714T
(lt)
|
2012-06-08 |
2022-05-10 |
Dupont Nutrition Biosciences Aps |
Polipeptidai, pasižymintys transgalaktozilinimo aktyvumu
|
US10232019B2
(en)
|
2012-07-25 |
2019-03-19 |
University Of Cincinnati |
Method of treating hyperglycemic disorders using apolipoprotein AIV
|
US9730980B2
(en)
|
2012-07-25 |
2017-08-15 |
University Of Cincinnati |
Method of treating type I diabetes using apolipoprotein A-IV
|
MX2015002099A
(es)
|
2012-08-22 |
2015-05-11 |
Dupont Nutrition Biosci Aps |
Variantes que tienen actividad glucoamilasa.
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
WO2014060401A1
(en)
|
2012-10-15 |
2014-04-24 |
Novo Nordisk Health Care Ag |
Coagulation factor vii polypeptides
|
MY173334A
(en)
|
2013-01-02 |
2020-01-16 |
Ichnos Sciences SA |
Antibodies that bind to tl1a and their uses
|
WO2014114801A1
(en)
|
2013-01-25 |
2014-07-31 |
Amgen Inc. |
Antibodies targeting cdh19 for melanoma
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
AU2014243700B2
(en)
|
2013-03-13 |
2019-01-24 |
Genentech, Inc. |
Formulations with reduced oxidation
|
JP6606059B2
(ja)
|
2013-03-13 |
2019-11-13 |
ジェネンテック, インコーポレイテッド |
酸化還元製剤
|
AR095399A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida, método
|
AR095398A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida
|
CA2906057A1
(en)
|
2013-03-13 |
2014-10-02 |
Genentech, Inc. |
Antibody formulations
|
WO2014151901A1
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Improvement of mammalian cell culture performance through surfactant supplementation of feed media
|
AU2013384204B2
(en)
|
2013-03-14 |
2017-03-16 |
Abbvie Inc. |
Low acidic species compositions and methods for producing and using the same
|
WO2014142882A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Protein purification using displacement chromatography
|
EP2970375A1
(en)
|
2013-03-14 |
2016-01-20 |
AbbVie Inc. |
Low acidic species compositions and methods for producing the same using displacement chromatography
|
CN105121628B
(zh)
|
2013-03-15 |
2020-03-24 |
豪夫迈·罗氏有限公司 |
具有抗氧化剂的细胞培养组合物和多肽生产方法
|
WO2014140368A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza m2 and cd3
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res (Munich) Gmbh |
Moléculas de unión para bcma y cd3
|
WO2014145768A2
(en)
|
2013-03-15 |
2014-09-18 |
Bp Corporation North America Inc. |
Use of non-fungal 5' utrs in filamentous fungi
|
US20140283157A1
(en)
|
2013-03-15 |
2014-09-18 |
Diadexus, Inc. |
Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
|
UY35484A
(es)
|
2013-03-15 |
2014-10-31 |
Amgen Res Munich Gmbh |
Molécula de unión de cadena simple que comprenden ABP de extremo N
|
DK3611180T3
(da)
|
2013-03-15 |
2022-02-28 |
Biomolecular Holdings Llc |
Hybrid immunoglobulin indeholdende ikke-peptidyl-binding
|
AR095348A1
(es)
|
2013-03-15 |
2015-10-07 |
Genentech Inc |
Medios de cultivo celular y métodos de producción de anticuerpos
|
WO2014146575A1
(en)
|
2013-03-19 |
2014-09-25 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
CA2904095A1
(en)
|
2013-03-27 |
2014-10-02 |
Genentech, Inc. |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
CA2910029A1
(en)
|
2013-05-31 |
2014-12-04 |
Genentech, Inc. |
Anti-wall teichoic antibodies and conjugates
|
EP3033097B1
(en)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Factor viii-xten fusions and uses thereof
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
TWI714022B
(zh)
|
2013-09-27 |
2020-12-21 |
美商建南德克公司 |
抗-pdl1抗體調配物
|
EP3069137A1
(en)
|
2013-11-05 |
2016-09-21 |
Novartis Ag |
Organic compounds
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
AR098708A1
(es)
|
2013-12-11 |
2016-06-08 |
Dupont Nutrition Biosci Aps |
Método para preparar un producto lácteo con un contenido estable de galacto-oligosacárido/s
|
MX2016007887A
(es)
|
2013-12-17 |
2016-10-28 |
Genentech Inc |
Metodos de tratamiento de canceres positivos a her2 usando antagonistas de union del eje de pd-1 y anticuerpos anti-her2.
|
SG11201604979WA
(en)
|
2013-12-17 |
2016-07-28 |
Genentech Inc |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
BR112016013741A2
(pt)
|
2013-12-17 |
2017-10-03 |
Genentech Inc |
Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos
|
CN106062005A
(zh)
|
2013-12-30 |
2016-10-26 |
医药生命融合研究团 |
抗krs单克隆抗体及其用途
|
BR112016014731A2
(pt)
|
2014-01-31 |
2017-09-19 |
Boehringer Ingelheim Int |
Anticorpos anti-baff
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
WO2015120075A2
(en)
|
2014-02-04 |
2015-08-13 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
SG10201807877TA
(en)
|
2014-03-14 |
2018-10-30 |
Daniel Capon |
Hybrid immunoglobulin containing non-peptidyl linkage
|
RU2710551C2
(ru)
|
2014-03-25 |
2019-12-27 |
Дженентек, Инк. |
Способы приготовления полоксамера для применения в клеточной культуральной среде
|
RU2016136716A
(ru)
|
2014-03-27 |
2018-04-28 |
Дженентек, Инк. |
Способы диагностики и лечения воспалительного заболевания кишечника
|
MX2016012779A
(es)
|
2014-03-31 |
2017-04-27 |
Genentech Inc |
Terapia de combinacion con agentes antiangiogénesis y agonistas de unión a ox40.
|
US11345908B2
(en)
|
2014-05-30 |
2022-05-31 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
EP3145951A1
(en)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
WO2016004197A1
(en)
|
2014-07-03 |
2016-01-07 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
|
US20160185848A1
(en)
|
2014-07-09 |
2016-06-30 |
Abbvie Inc. |
Methods for modulating the glycosylation profile of recombinant proteins using sugars
|
EP3708679A1
(en)
|
2014-07-24 |
2020-09-16 |
Boehringer Ingelheim International GmbH |
Biomarkers useful in the treatment of il-23a related diseases
|
MX2017001403A
(es)
|
2014-07-31 |
2017-07-07 |
Amgen Res (Munich) Gmbh |
Constructo de anticuerpo de cadena individual biespecifico con distribucion mejorada de tejido.
|
TW201609812A
(zh)
|
2014-07-31 |
2016-03-16 |
安美基研究(慕尼黑)公司 |
最佳化之跨物種特異性雙特異性單鏈抗體構築體
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
WO2016044334A1
(en)
|
2014-09-15 |
2016-03-24 |
Genentech, Inc. |
Antibody formulations
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
MX2017004947A
(es)
|
2014-10-24 |
2017-06-29 |
Bristol Myers Squibb Co |
Polipeptidos del factor de crecimiento de fibroblastos 2 (fgf-21) modificados y usos de los mismos.
|
CA2966718A1
(en)
|
2014-11-07 |
2016-05-12 |
Dupont Nutrition Biosciences Aps |
Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase
|
US20160166685A1
(en)
|
2014-11-17 |
2016-06-16 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
MX2017007055A
(es)
|
2014-12-03 |
2017-11-08 |
Genentech Inc |
Conjugados de anticuerpo rifamicina anti-staphylococcus aureus y usos de estos.
|
AU2016215227A1
(en)
|
2015-02-04 |
2017-09-21 |
Assistance Publique-Hopitaux De Paris |
Mutant smoothened and methods of using the same
|
IL307578A
(en)
|
2015-02-04 |
2023-12-01 |
Boehringer Ingelheim Int |
Methods for treating inflammatory diseases
|
CN108064267A
(zh)
|
2015-02-09 |
2018-05-22 |
丹尼斯科美国公司 |
真菌菌株及使用方法
|
CN107257693A
(zh)
|
2015-02-26 |
2017-10-17 |
豪夫迈·罗氏有限公司 |
治疗Crohn病的整联蛋白β7拮抗剂和方法
|
WO2016141111A1
(en)
|
2015-03-03 |
2016-09-09 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
WO2016144773A1
(en)
|
2015-03-06 |
2016-09-15 |
Abbvie Inc. |
Arabinosylated glycoproteins
|
WO2016161410A2
(en)
|
2015-04-03 |
2016-10-06 |
Xoma Technology Ltd. |
Treatment of cancer using inhibitors of tgf-beta and pd-1
|
CN107530425A
(zh)
|
2015-04-14 |
2018-01-02 |
勃林格殷格翰国际有限公司 |
治疗疾病的方法
|
IL255076B2
(en)
|
2015-04-17 |
2023-10-01 |
Amgen Res Munich Gmbh |
CDH3 and CD3 bispecific antibody constructs
|
BR112017024579A2
(pt)
|
2015-05-22 |
2018-07-31 |
Dupont Nutrition Biosci Aps |
acetolactato descarboxilase
|
AU2016271142A1
(en)
|
2015-05-29 |
2017-11-23 |
Genentech, Inc. |
PD-L1 promoter methylation in cancer
|
CN107771076A
(zh)
|
2015-06-17 |
2018-03-06 |
豪夫迈·罗氏有限公司 |
使用pd‑1轴结合拮抗剂和紫杉烷治疗局部晚期或转移性乳腺癌的方法
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI793062B
(zh)
|
2015-07-31 |
2023-02-21 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
AU2016301303B2
(en)
|
2015-08-03 |
2021-10-07 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
TW202340452A
(zh)
|
2015-08-04 |
2023-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
EP3334763A4
(en)
|
2015-08-11 |
2019-04-03 |
Wuxi Biologics (Cayman) Inc. |
NOVEL ANTI-PD-1 ANTIBODIES
|
EP3344282B8
(en)
|
2015-09-02 |
2020-12-23 |
DuPont Nutrition Biosciences ApS |
Glycoside hydrolases and their use in preventing and/or treating a pathogenic infection in an animal
|
JP7175760B2
(ja)
|
2015-09-07 |
2022-11-21 |
ヘルムホルツ ツェントゥルム ミュンヘン ドイチェス フォルシュングスツェントゥルム フューア ゲズントハイト ウント ウムヴェルト (ゲーエムベーハー) |
新規なigfr様レセプター及びその使用
|
TWI733695B
(zh)
|
2015-09-18 |
2021-07-21 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
AU2016380988B2
(en)
|
2015-12-30 |
2022-07-21 |
Genentech, Inc. |
Formulations with reduced degradation of polysorbate
|
SG11201804951SA
(en)
|
2015-12-30 |
2018-07-30 |
Genentech Inc |
Use of tryptophan derivatives for protein formulations
|
MD3411402T2
(ro)
|
2016-02-03 |
2022-05-31 |
Amgen Res Munich Gmbh |
Constructe de anticorpi bispecifici BCMA și CD3 de angajare a celulei T
|
TN2018000266A1
(en)
|
2016-02-03 |
2020-01-16 |
Amgen Res Munich Gmbh |
Psma and cd3 bispecific t cell engaging antibody constructs.
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
AU2017213826A1
(en)
|
2016-02-04 |
2018-08-23 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
US10870701B2
(en)
|
2016-03-15 |
2020-12-22 |
Generon (Shanghai) Corporation Ltd. |
Multispecific fab fusion proteins and use thereof
|
CN109153719B
(zh)
|
2016-03-15 |
2022-12-30 |
中外制药株式会社 |
使用pd-1轴结合拮抗剂和抗gpc3抗体治疗癌症的方法
|
US10822416B2
(en)
|
2016-03-23 |
2020-11-03 |
Mabspace Biosciences (Suzhou) Co., Ltd |
Anti-PD-L1 antibodies
|
CN109328069B
(zh)
|
2016-04-15 |
2023-09-01 |
亿一生物医药开发(上海)有限公司 |
Il-22在治疗坏死性小肠结肠炎中的用途
|
EP3974451A3
(en)
|
2016-04-15 |
2022-07-06 |
Boehringer Ingelheim International GmbH |
Methods of treating inflammatory diseases
|
US10851159B2
(en)
|
2016-06-02 |
2020-12-01 |
Bloom Diagnostics Ag |
Antibodies that bind to human anti-Müllerian hormone (AMH) and their uses
|
BR112018077458A2
(pt)
|
2016-06-30 |
2019-04-02 |
Danisco Us Inc. |
proteases aspárticas
|
JP7148493B2
(ja)
|
2016-08-01 |
2022-10-05 |
ゾーマ (ユーエス) リミテッド ライアビリティ カンパニー |
副甲状腺ホルモン受容体1(pth1r)抗体およびその使用
|
EP3497129A1
(en)
|
2016-08-08 |
2019-06-19 |
H. Hoffnabb-La Roche Ag |
Therapeutic and diagnostic methods for cancer
|
EP3512941B1
(en)
|
2016-09-16 |
2021-03-24 |
DuPont Nutrition Biosciences ApS |
Acetolactate decarboxylase variants having improved specific activity
|
US11111313B2
(en)
|
2016-09-20 |
2021-09-07 |
WuXi Biologics Ireland Limited |
Anti-PCSK9 antibodies
|
CN109982576B
(zh)
|
2016-09-23 |
2024-03-22 |
杜邦营养生物科学有限公司 |
低PH活性α-1,4/1,6-糖苷水解酶作为反刍动物的饲料添加剂用于增强淀粉消化的用途
|
BR112019005944A2
(pt)
|
2016-09-28 |
2019-06-11 |
Musc Foudation For Res Development |
anticorpos que se ligam à interleucina 2 e usos dos mesmos
|
EP3523415A1
(en)
|
2016-10-04 |
2019-08-14 |
Danisco US Inc. |
Protein production in filamentous fungal cells in the absence of inducing substrates
|
US20180105588A1
(en)
|
2016-10-14 |
2018-04-19 |
Boehringer Ingelheim International Gmbh |
Methods of treating diseases
|
US11007254B2
(en)
|
2016-10-17 |
2021-05-18 |
Musc Foundation For Research Development |
Compositions and methods for treating central nervous system injury
|
WO2018093752A1
(en)
|
2016-11-15 |
2018-05-24 |
Danisco Us Inc. |
Filamentous fungi with improved protein production
|
US20190352374A1
(en)
|
2017-01-30 |
2019-11-21 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel igfr_like 2 receptor and uses thereof
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
KR102670432B1
(ko)
|
2017-02-08 |
2024-05-28 |
브리스톨-마이어스 스큅 컴퍼니 |
약동학적 인핸서를 포함하는 변형된 렐락신 폴리펩티드 및 그의 용도
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
WO2018164876A1
(en)
|
2017-03-06 |
2018-09-13 |
Dupont Nutrition Biosciences Aps |
Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
|
CN110753702B
(zh)
|
2017-03-15 |
2022-09-20 |
清华大学 |
抗trkb抗体
|
WO2018182284A1
(ko)
|
2017-03-27 |
2018-10-04 |
재단법인 의약바이오컨버젼스연구단 |
세포 외막에 노출되는 라이실-tRNA 합성효소 N-말단 영역에 특이적으로 결합하는 항체
|
WO2018183173A1
(en)
|
2017-03-27 |
2018-10-04 |
Boehringer Ingelheim International Gmbh |
Anti il-36r antibodies combination therapy
|
EP3615569A1
(en)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
BR112019022751A2
(pt)
|
2017-05-05 |
2020-05-19 |
Amgen Inc |
composição farmacêutica compreendendo construtos de anticorpos biespecíficos para armazenamento e administração melhorados
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
WO2019018629A1
(en)
|
2017-07-19 |
2019-01-24 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING INFECTION WITH HEPATITIS B VIRUS
|
WO2019089544A1
(en)
|
2017-11-01 |
2019-05-09 |
Tufts Medical Center, Inc. |
Bispecific antibody constructs and methods of use
|
EA202091422A1
(ru)
|
2017-12-11 |
2020-08-28 |
Эмджен Инк. |
Способ непрерывного производства продуктов на основе биспецифических антител
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
CA3092037A1
(en)
|
2018-02-21 |
2019-08-29 |
Celgene Corporation |
Bcma-binding antibodies and uses thereof
|
KR102340989B1
(ko)
|
2018-03-28 |
2021-12-20 |
에이비온 주식회사 |
클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
|
CN112334485A
(zh)
|
2018-04-06 |
2021-02-05 |
百进生物科技公司 |
抗-四次穿膜蛋白33药剂及其组合物以及制备和使用方法
|
WO2019213416A1
(en)
|
2018-05-02 |
2019-11-07 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
AU2019270184A1
(en)
|
2018-05-18 |
2020-11-26 |
Bioverativ Therapeutics Inc. |
Methods of treating hemophilia A
|
KR20210024550A
(ko)
|
2018-06-23 |
2021-03-05 |
제넨테크, 인크. |
Pd-1 축 결합 길항제, 백금 제제, 및 토포이소머라제 ii 억제제를 이용한 폐암 치료 방법
|
CA3101469A1
(en)
|
2018-06-29 |
2020-01-02 |
Boehringer Ingelheim International Gmbh |
Anti-cd40 antibodies for use in treating autoimmune disease
|
US20210278406A1
(en)
|
2018-07-13 |
2021-09-09 |
Varct Diagnostic Aps |
Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
|
KR20210042936A
(ko)
|
2018-08-08 |
2021-04-20 |
제넨테크, 인크. |
단백질 제제를 위한 트립토판 유도체 및 l-메티오닌의 용도
|
CA3111809A1
(en)
|
2018-09-21 |
2020-03-26 |
Genentech, Inc. |
Diagnostic methods for triple-negative breast cancer
|
CN113365697B
(zh)
|
2018-09-25 |
2024-07-19 |
百进生物科技公司 |
抗tlr9药剂和组合物及其制备方法和使用方法
|
AR116548A1
(es)
|
2018-09-28 |
2021-05-19 |
Amgen Inc |
Anticuerpos contra bcma soluble
|
AU2019356564A1
(en)
|
2018-10-11 |
2021-04-29 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
SG11202103124WA
(en)
|
2018-10-23 |
2021-04-29 |
Glycardial Diagnostics S L |
Antibodies specific for glycosylated apoj and uses thereof
|
CA3131705A1
(en)
|
2019-03-27 |
2020-10-01 |
Umc Utrecht Holding B.V. |
Engineered iga antibodies and methods of use
|
CR20210559A
(es)
|
2019-05-09 |
2021-12-23 |
Boehringer Ingelheim Int |
Anticuerpos anti-sema3a y sus usos para tratar enfermedades oculares
|
EP3978532A4
(en)
|
2019-05-24 |
2023-10-18 |
Sanyou Biopharmaceuticals Co., Ltd. |
NEW BINDING MOLECULE CLDN18.2
|
TW202045711A
(zh)
|
2019-06-13 |
2020-12-16 |
美商安進公司 |
生物製品製造中基於生物量之自動灌注控制
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
KR102478445B1
(ko)
|
2019-07-18 |
2022-12-20 |
주식회사 큐어바이오테라퓨틱스 |
Wrs 단백질에 특이적으로 결합하는 항체 및 이의 용도
|
EP4021479A2
(en)
|
2019-08-27 |
2022-07-06 |
Tonix Pharma Limited |
Modified tff2 polypeptides
|
CA3152946A1
(en)
|
2019-09-10 |
2021-03-18 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein l capture dynamic binding capacity
|
KR102442204B1
(ko)
|
2019-09-20 |
2022-09-08 |
경북대학교 산학협력단 |
Cox2 단백질의 아세틸화 검출용 항체 및 이의 용도
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
CA3156683A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
METHOD FOR REDUCING AGGREGATE FORMATION IN DOWNSTREAM PROCESSING OF BI-SPECIFIC ANTIGEN-BINDING MOLECULES
|
WO2021122687A1
(en)
|
2019-12-19 |
2021-06-24 |
Basf Se |
Increasing space-time-yield, carbon-conversion-efficiency and carbon substrate flexibility in the production of fine chemicals
|
CN115135762A
(zh)
|
2019-12-20 |
2022-09-30 |
巴斯夫欧洲公司 |
降低萜烯的毒性和增加微生物的生产潜力
|
US20230093169A1
(en)
|
2020-01-22 |
2023-03-23 |
Amgen Research (Munch) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CN113461817A
(zh)
|
2020-03-31 |
2021-10-01 |
苏州泽璟生物制药股份有限公司 |
一种抗人cd47抗体及其抗原结合片段、制备方法和应用
|
US20210371809A1
(en)
|
2020-04-15 |
2021-12-02 |
Genentech, Inc. |
Copper loss mitigation
|
CR20220596A
(es)
|
2020-05-26 |
2023-01-23 |
Boehringer Ingelheim Int |
Anticuerpos anti-pd-1
|
CA3176246A1
(en)
|
2020-06-02 |
2021-12-09 |
Arcus Biosciences, Inc. |
Antibodies to tigit
|
US20210388064A1
(en)
|
2020-06-15 |
2021-12-16 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus antibodies and fragments thereof
|
MX2022015877A
(es)
|
2020-06-16 |
2023-01-24 |
Genentech Inc |
Metodos y composiciones para tratar cancer de mama triple negativo.
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
WO2022093640A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2c agents and compositions and methods for making and using the same
|
WO2022093641A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2a agents and compositions and methods for making and using the same
|
WO2022096700A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Research (Munich) Gmbh |
Polypeptide constructs selectively binding to cldn6 and cd3
|
EP4240407A1
(en)
|
2020-11-06 |
2023-09-13 |
Amgen Inc. |
Antigen binding domain with reduced clipping rate
|
JP2023547661A
(ja)
|
2020-11-06 |
2023-11-13 |
アムジエン・インコーポレーテツド |
Cd3に結合するポリペプチド構築物
|
CN112480248B
(zh)
|
2020-11-24 |
2023-05-05 |
三优生物医药(上海)有限公司 |
与cld18a2特异性结合的分子
|
CN117043181A
(zh)
|
2020-12-18 |
2023-11-10 |
基尼科萨制药有限公司 |
蛋白质组合物以及其产生和使用方法
|
CA3215594A1
(en)
|
2021-04-02 |
2022-10-06 |
Agnieszka KIELCZEWSKA |
Mageb2 binding constructs
|
CA3226102A1
(en)
|
2021-07-23 |
2023-01-26 |
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) |
Igfr-l1 antibodies and uses thereof
|
WO2023105087A1
(en)
|
2021-12-10 |
2023-06-15 |
Tubulis Gmbh |
Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
WO2023173011A1
(en)
|
2022-03-09 |
2023-09-14 |
Bristol-Myers Squibb Company |
Transient expression of therapeutic proteins
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|
WO2024083925A2
(en)
|
2022-10-18 |
2024-04-25 |
Tubulis Gmbh |
Novel anti-napi2b antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof
|
WO2024083953A1
(en)
|
2022-10-18 |
2024-04-25 |
Tubulis Gmbh |
Novel anti-tpbg antibody and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof
|